Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study

Hsiao S.-M.TING-CHEN CHANGCHI-HAU CHENWen-Yih W.U.HO-HSIUNG LIN2021-03-032021-03-0320181757-5664https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018923385&doi=10.1111%2fluts.12167&partnerID=40&md5=63fcccc77783bf9b3e0fd353453082ddhttps://scholars.lib.ntu.edu.tw/handle/123456789/550166[SDGs]SDG3Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Studyjournal article10.1111/luts.12167284361452-s2.0-85018923385